Dong Lee, MD
Geriatric Medicine · Los Angeles, CANPI 1134109200
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 278 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $26.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amarin Pharma, Inc.$1K
- Amgen$1K
- Penumbra, Inc.$542
- Lilly USA, LLC$482
- AstraZeneca$360
- plus $2K from 26 others
What the payments were for
- Travel & lodging$3214%
- Food & beverage$7,11996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $1,321 |
| Amarin Pharma, Inc. | 49 | $1,310 |
| Amgen(2 entities) | 47 | $1,048 |
| Penumbra, Inc. | 5 | $542 |
| Lilly USA, LLC | 20 | $482 |
| AstraZeneca | 19 | $360 |
| Boehringer Ingelheim | 12 | $300 |
| Scilex Pharmaceuticals Inc. | 15 | $270 |
| Inspiremd Ltd | 3 | $233 |
| Aimmune Therapeutics, Inc. | 9 | $227 |
| Nestle Healthcare Nutrition Inc. | 8 | $185 |
| Ironwood Pharmaceuticals, Inc | 7 | $152 |
| Gilead | 1 | $125 |
| Pfizer | 4 | $109 |
| Redhill Biopharma Inc. | 6 | $109 |
| GSK | 4 | $98 |
| Novo Nordisk | 4 | $79 |
| Novartis | 4 | $73 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Merck | 3 | $53 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Bayer | 1 | $23 |
| Edwards Lifesciences | 1 | $22 |
| Vivus LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$451
- Vascepa$255
- Creon$250
- CGuard Prime Carotid Stent System$209
- Vemlidy$125
- LINZESS$123
How this compares
$7,439 in reported general payments places this provider in the 90th percentile of 494 geriatric medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 273 | $342,285 |
| VascepaIcosapent Ethyl | 739 | $308,965 |
| JanuviaSitagliptin Phosphate | 223 | $201,095 |
| JardianceEmpagliflozin | 165 | $123,372 |
| TradjentaLinagliptin | 179 | $120,091 |
| ZenpepLipase/Protease/Amylase | 79 | $107,525 |
| EliquisApixaban | 126 | $104,357 |
| ZtlidoLidocaine | 174 | $90,215 |
| RestasisCyclosporine | 91 | $72,622 |
| JanumetSitagliptin Phos/Metformin Hcl | 72 | $56,460 |
| TrulicityDulaglutide | 57 | $54,200 |
| LinzessLinaclotide | 74 | $53,459 |
| FarxigaDapagliflozin Propanediol | 58 | $50,584 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 50 | $45,139 |
| ProliaDenosumab | 21 | $35,356 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Restasis, Linzess | $1,321 | $468,366438 claims |
| MerckJanuvia, Janumet, Janumet Xr | $53 | $302,694345 claims |
| Boehringer IngelheimJardiance, Tradjenta | $300 | $243,464344 claims |
| Aimmune Therapeutics, Inc.Zenpep | $227 | $107,52579 claims |
| PfizerEliquis | $109 | $104,357126 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $270 | $90,215174 claims |
| AstraZenecaFarxiga, Brilinta | $360 | $60,50181 claims |
| Lilly USA, LLCTrulicity | $482 | $54,20057 claims |
| AmgenProlia | $1,048 | $35,35621 claims |
| GSKBreo Ellipta, Shingrix, Anoro Ellipta | $98 | $21,36563 claims |
| IBSA Pharma Inc.Licart | $18 | $18,66013 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $14,54932 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 494 geriatric medicine providers in California.
Other geriatric medicine in Los Angeles
- Wayne ChenLos Angeles$40K
- Arman HekmatiLos Angeles$14K
- Sylvia CarlisleLos Angeles$4K
- Joshua ChodoshLos Angeles$4K
- Azmy GhalyLos Angeles$4K
- Jo Ann PullenLos Angeles$3K
- Robert FeldmanLaguna Hills$1.2M
- Oscar ChienSan Gabriel$208K
- Anders NybergSan Diego$160K
- Paul AisenSan Diego$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.